Spots Global Cancer Trial Database for placebo oral tablet

Every month we try and update this database with for placebo oral tablet cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies	NCT03151057	B Cells-Tumors B Cell Chronic ... Follicular Lymp... Mantle Cell Lym... Large B-Cell Di...	Idelalisib 100 ... Placebo Oral Ta...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment	NCT03024684	HepatoCellular ...	Atorvastatin Placebo Oral Ta...	20 Years - 75 Years	Chiayi Christian Hospital
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence	NCT03219372	Hepatocellular ... Liver Cirrhoses	Pravastatin Pil... Placebo Oral Ta...	18 Years -	Cedars-Sinai Medical Center
Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.	NCT04321850	Oral Mucositis	Zinc Sulfate 50... Placebo oral ta...	3 Years - 18 Years	National Institute of Pediatrics, Mexico
Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy	NCT03674294	Gastrointestina... Chemotherapy-in...	Aprepitant Palonosetron Dexamethasone Placebo Oral Ta...	18 Years - 50 Years	Sun Yat-sen University
Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride	NCT03333265	Colorectal Aden...	100mg Berberine... 300mg Berberine... Placebo Oral Ta...	18 Years - 65 Years	Xijing Hospital of Digestive Diseases
The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy	NCT03142542	Prostate Cancer...	ZYDENA TAB.75mg... Placebo Oral Ta...	20 Years - 70 Years	Samsung Medical Center
Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer	NCT04460807	Ovarian Cancer	Exemestane Placebo oral ta...	18 Years -	Ente Ospedaliero Ospedali Galliera
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study	NCT03186404	Cancer Heart Failure Cardiotoxicity	Atorvastatin Placebo oral ta...	18 Years -	University Health Network, Toronto
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate	NCT04136353	Prostate Cancer	Darolutamide Placebo oral ta... Luteinizing Hor... External Beam R...	18 Years -	University of Sydney
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.	NCT03361969	Prostatic Neopl...	Estetrol Placebo Oral Ta...	18 Years -	Pantarhei Oncology B.V.
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst	NCT03456570	Functional Ovar... Progesterone	Dydrogesterone ... Placebo Oral Ta...	18 Years - 44 Years	Assiut University
Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome	NCT03630341	Polycystic Ovar...	Clomiphene Citr... L-carnitine Placebo Oral Ta...	18 Years - 35 Years	Assiut University
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)	NCT04093505	Acute Myeloid L...	Gemtuzumab Ozog... Gemtuzumab Ozog... Glasdegib Placebo Oral Ta...	60 Years -	University Hospital Heidelberg
Aspirin in Colorectal Cancer Liver Metastases	NCT03326791	Colorectal Canc... Colorectal Canc... Liver Metastase...	Acetylsalicylic... Placebo Oral Ta...	18 Years -	Oslo University Hospital
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)	NCT04107727	Acute Myeloid L...	Quizartinib Placebo oral ta... Cytarabine Idarubicin	18 Years - 70 Years	PETHEMA Foundation
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study	NCT03186404	Cancer Heart Failure Cardiotoxicity	Atorvastatin Placebo oral ta...	18 Years -	University Health Network, Toronto
Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)	NCT04392128	COVID19 Hematologic Mal...	Hydroxychloroqu... Azithromycin 25... Placebo oral ta... Placebo oral ca...	18 Years -	Institut de cancérologie Strasbourg Europe
Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen	NCT03844685	Breast Cancer	Promensil Placebo Oral Ta...	18 Years - 60 Years	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.	NCT04321850	Oral Mucositis	Zinc Sulfate 50... Placebo oral ta...	3 Years - 18 Years	National Institute of Pediatrics, Mexico
Curcumin in Advanced Cervical Cancer	NCT04294836	Cervical Cancer...	Curcumin Placebo oral ta...	18 Years - 70 Years	Instituto Nacional de Cancerologia, Columbia
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients	NCT04116411	Glioblastoma Mu...	Valganciclovir ... Temozolomide 12... Radiotherapy 60... Placebo oral ta...	18 Years -	Karolinska Institutet
Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)	NCT04392128	COVID19 Hematologic Mal...	Hydroxychloroqu... Azithromycin 25... Placebo oral ta... Placebo oral ca...	18 Years -	Institut de cancérologie Strasbourg Europe
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst	NCT03456570	Functional Ovar... Progesterone	Dydrogesterone ... Placebo Oral Ta...	18 Years - 44 Years	Assiut University
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)	NCT03743064	Cachexia; Cance... Non Small Cell ...	anamorelin HCl Placebo Oral Ta...	18 Years -	Helsinn Healthcare SA
Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia	NCT04748523	Anorexia Non-small Cell ...	Mirtazapine Placebo Oral Ta...	18 Years -	Instituto Nacional de Cancerologia de Mexico
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies	NCT03151057	B Cells-Tumors B Cell Chronic ... Follicular Lymp... Mantle Cell Lym... Large B-Cell Di...	Idelalisib 100 ... Placebo Oral Ta...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.	NCT03137537	Lymphoma Autonomic Imbal... Cancer Survivor...	Ivabradine Placebo Oral Ta...	18 Years - 80 Years	Dana-Farber Cancer Institute
Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis	NCT03428711	Superficial Ven...	Mesoglycan Oral... Placebo Oral Ta...	18 Years - 90 Years	Quovadis Associazione
Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer	NCT03588091	HER2-positive B...	Pyrotinib Placebo Oral Ta... Trastuzumab Docetaxel	18 Years - 75 Years	Jiangsu HengRui Medicine Co., Ltd.
The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy	NCT03142542	Prostate Cancer...	ZYDENA TAB.75mg... Placebo Oral Ta...	20 Years - 70 Years	Samsung Medical Center
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction	NCT03934905	Anthracycline R...	sulforaphane Placebo Oral Ta...	18 Years - 89 Years	Texas Tech University Health Sciences Center
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study	NCT03186404	Cancer Heart Failure Cardiotoxicity	Atorvastatin Placebo oral ta...	18 Years -	University Health Network, Toronto
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence	NCT03219372	Hepatocellular ... Liver Cirrhoses	Pravastatin Pil... Placebo Oral Ta...	18 Years -	Cedars-Sinai Medical Center
Interventions for Reading Disabilities in NF1	NCT02964884	Neurofibromatos... Learning Disabi... Reading Disabil... NF1	Lovastatin reading tutorin... Placebo Oral Ta... Other Academic ...	8 Years - 20 Years	Vanderbilt University
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction	NCT03934905	Anthracycline R...	sulforaphane Placebo Oral Ta...	18 Years - 89 Years	Texas Tech University Health Sciences Center
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions	NCT03685409	Oral Cancer	Metformin Hydro... Placebo Oral Ta...	20 Years - 70 Years	Cairo University
Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome	NCT06101147	PCOS Vitamin D	Vitamin D3 Placebo Oral Ta...	18 Years - 45 Years	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy	NCT02802267	Acute Myelogeno...	Inecalcitol Placebo Oral Ta...	65 Years -	Hybrigenics Corporation
Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer	NCT03400709	Cisplatin Adver... Hearing Loss Ot...	N Acetylcystein... Placebo Oral Ta...	18 Years -	Hospital San Juan de Dios, Santiago
Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer	NCT04264676	Colorectal Canc... Colorectal Canc...	Metronidazole O... Placebo oral ta...	18 Years - 75 Years	Shanghai Jiao Tong University School of Medicine
Effect of Hemp-CBD on Patients With CIPN	NCT04398446	Chemotherapy-in... Colorectal Canc... Colorectal Canc... Breast Cancer Ovarian Cancer Uterine Cancer Pancreatic Canc...	Hemp-based CBD Placebo oral ta...	21 Years -	Main Line Health
Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer	NCT03170115	Rectal Cancer, ... Locally Advance... Chemoradiation	Aspirin Placebo Oral Ta...	18 Years - 75 Years	Instituto Nacional de Cancer, Brazil
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.	NCT04175301	Malignant Gliom...	Hydrogen Placebo oral ta...	18 Years -	Stony Brook University
Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer	NCT03048877	Differentiated ...	Apatinib Oral T... Placebo Oral Ta...	18 Years -	Peking Union Medical College Hospital
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma	NCT04066725	Melanoma (Skin)	Aspirin 81 mg Aspirin 325mg Placebo oral ta...	18 Years -	University of Utah
Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers	NCT03077477	Neoplasms Medication Toxi... Tolerance	AMXT 1501 Placebo Oral Ta...	18 Years - 55 Years	Aminex Therapeutics, Inc.
Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy	NCT03581773	Mucositis	Folic Acid Placebo Oral Ta...	18 Years -	University of Aarhus
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.	NCT04175301	Malignant Gliom...	Hydrogen Placebo oral ta...	18 Years -	Stony Brook University
Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)	NCT02970162	Lambert-Eaton M...	Amifampridine P... Placebo Oral Ta...	18 Years -	Catalyst Pharmaceuticals, Inc.
Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery	NCT04294953	Colorectal Canc...	Duloxetine Placebo oral ta...	18 Years - 65 Years	Assiut University
Curcumin in Advanced Cervical Cancer	NCT04294836	Cervical Cancer...	Curcumin Placebo oral ta...	18 Years - 70 Years	Instituto Nacional de Cancerologia, Columbia
Barretts oEsophageal Resection With Steroid Therapy Trial	NCT02004782	Barrett Esophag... Esophageal Sten...	Prednisolone Placebo Oral Ta...	18 Years - 90 Years	Western Sydney Local Health District
Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen	NCT03844685	Breast Cancer	Promensil Placebo Oral Ta...	18 Years - 60 Years	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.	NCT04387630	Breast Cancer	Metformin Placebo oral ta...	18 Years - 65 Years	Mansoura University
Evaluation of Naloxegol in the Prevention of POI After Cystectomy	NCT04219046	Bladder Cancer Cystostomy; Com...	Naloxégol oxala... Placebo oral ta...	18 Years -	Institut Paoli-Calmettes
Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma	NCT03951571	Soft Tissue Sar... High Grade Sarc...	Anlotinib Hydro... Placebo Oral Ta...	18 Years -	Fudan University
Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.	NCT03722680	Oxaliplatin-ind...	Riluzole Placebo Oral Ta...	18 Years -	UNICANCER
Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies	NCT03353753	Gastrointestina...	DCC-2618 Placebo Oral Ta...	18 Years -	Deciphera Pharmaceuticals LLC
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients	NCT04116411	Glioblastoma Mu...	Valganciclovir ... Temozolomide 12... Radiotherapy 60... Placebo oral ta...	18 Years -	Karolinska Institutet
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)	NCT03743051	Cachexia; Cance... Non Small Cell ...	Anamorelin Hydr... Placebo Oral Ta...	18 Years -	Helsinn Healthcare SA
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)	NCT04093505	Acute Myeloid L...	Gemtuzumab Ozog... Gemtuzumab Ozog... Glasdegib Placebo Oral Ta...	60 Years -	University Hospital Heidelberg
Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)	NCT02970162	Lambert-Eaton M...	Amifampridine P... Placebo Oral Ta...	18 Years -	Catalyst Pharmaceuticals, Inc.
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study	NCT03186404	Cancer Heart Failure Cardiotoxicity	Atorvastatin Placebo oral ta...	18 Years -	University Health Network, Toronto
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)	NCT04107727	Acute Myeloid L...	Quizartinib Placebo oral ta... Cytarabine Idarubicin	18 Years - 70 Years	PETHEMA Foundation
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.	NCT04175301	Malignant Gliom...	Hydrogen Placebo oral ta...	18 Years -	Stony Brook University
Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia	NCT04748523	Anorexia Non-small Cell ...	Mirtazapine Placebo Oral Ta...	18 Years -	Instituto Nacional de Cancerologia de Mexico
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG	NCT03304054	Myasthenia Grav...	Amifampridine P... Placebo Oral Ta...	18 Years -	Catalyst Pharmaceuticals, Inc.
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included	NCT03491410	Breast Cancer	Aspirin Low Dos... Placebo Oral Ta...	18 Years -	Centro Hospitalar Lisboa Ocidental
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers	NCT03471078	Chemotherapy-in...	Avatrombopag Placebo Oral Ta...	18 Years -	Sobi, Inc.
The MASTER Study (MAmmary Cancer STatin ER Positive Study)	NCT04601116	Breast Cancer F... Estrogen Recept...	Atorvastatin 80... Placebo oral ta...	18 Years -	Aarhus University Hospital
The MASTER Study (MAmmary Cancer STatin ER Positive Study)	NCT04601116	Breast Cancer F... Estrogen Recept...	Atorvastatin 80... Placebo oral ta...	18 Years -	Aarhus University Hospital
Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis	NCT03428711	Superficial Ven...	Mesoglycan Oral... Placebo Oral Ta...	18 Years - 90 Years	Quovadis Associazione

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: